Literature DB >> 8556526

Role of cytoskeletal elements in expression of monocyte urokinase plasminogen activator receptor, activation-associated antigen Mo3.

R Washington1, P Dore-Duffy.   

Abstract

Peripheral blood monocytes exposed to bacterial products, phorbol esters, cyclic AMP, and cyclic AMP analogs express cell surface activation protein Mo3, which is the human urokinase plasminogen activator receptor (uPA-R). uPA-R is expressed by circulating monocytes from patients with multiple sclerosis (MS). We examined the role of cytoskeletal elements in the surface expression and subcellular distribution of uPA-R in nonactivated and lipopolysaccharide-activated monocytes and in monocytes from patients with MS. By using immunofluorescence techniques and confocal laser microscopy, we found that in unactivated monocytes, cytoplasmic uPA-R is found to one side of the nucleus, colocalizing with the Golgi. Upon activation with lipopolysaccharide, cytoplasmic Mo3-uPA-R becomes dispersed throughout the cytoplasm and projections concomitant with an increase in the monocyte perimeter (spreading). Cytoplasmic dispersion, as well as cell surface deposition, is dependent on microtubule integrity. Cell surface deposition of uPA-R upon activation is reduced by colchicine, which disrupts microtubules; however, once associated at the cell surface, uPA-R becomes associated with microfilaments via vinculin. Disruption of microfilaments with cytochalasin also alters surface expression of immunologically reactive uPA-R, as well as the distribution pattern. Monocytes from patients with MS display the uPA-R distribution pattern characteristic of an activated monocyte.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556526      PMCID: PMC368399          DOI: 10.1128/cdli.1.6.714-721.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

Review 1.  Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system.

Authors:  J D Vassalli; A Wohlwend; D Belin
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells.

Authors:  R L Cohen; X P Xi; C W Crowley; B K Lucas; A D Levinson; M A Shuman
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

Review 3.  The receptor for human urokinase: a potential target for anti-invasive and anti-metastatic therapy.

Authors:  M T Masucci; F Blasi
Journal:  Thromb Res Suppl       Date:  1990

4.  GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.

Authors:  I Stefanová; V Horejsí; I J Ansotegui; W Knapp; H Stockinger
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

5.  Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.

Authors:  M J Niedbala; A C Sartorelli
Journal:  Cancer Commun       Date:  1990

6.  Expression of monocyte activation antigen Mo3 on the surface of peripheral blood monocytes from patients with multiple sclerosis.

Authors:  P Dore-Duffy; C Donovan; R F Todd
Journal:  Neurology       Date:  1992-08       Impact factor: 9.910

7.  cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.

Authors:  H Y Min; R Semnani; I F Mizukami; K Watt; R F Todd; D Y Liu
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

8.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.

Authors:  A Estreicher; J Mühlhauser; J L Carpentier; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

9.  Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.

Authors:  C A Hébert; J B Baker
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

10.  Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes.

Authors:  I I Singer; S Scott; G L Hall; G Limjuco; J Chin; J A Schmidt
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  1 in total

1.  Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Authors:  R Balabanov; D Lisak; T Beaumont; R P Lisak; P Dore-Duffy
Journal:  Clin Diagn Lab Immunol       Date:  2001-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.